Two stocks in Healthcare
Novartis vs Ypsomed Holding: profit, growth, debt and price compared
Ypsomed Holding is stronger on 4 of 7 figures: profit margin, debt, analysts' view and price trend. Novartis is stronger on 3: sales growth, price for its expected profit and dividend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| NovartisNOVN.SW | Ypsomed HoldingYPSN.SW | |
|---|---|---|
| Net margin | 17.5% | Stronger: 30.4% |
| Revenue growth, past year | Stronger: +4.70% | −13.30% |
| Debt to equity | 128.6% | Stronger: 34.9% |
| Forward P/E | Stronger: 15.9× | 28.8× |
| Dividend yield | Stronger: 2.78% | 1.04% |
| Analysts | Hold · 22 | Stronger: Buy · 14 |
| From its 200-day average | +9.2% | Stronger: +21.2% |
Share price over the past year
- Novartis+24.3%
- Ypsomed Holding+34.1%
17 Nov 202518 Nov 2026
Novartis or Ypsomed Holding: which is stronger?
- YPSN.SW
Which is more profitable?
Ypsomed Holding keeps more of each sale as profit: 30.4% against 17.5%.
- NOVN.SW
Which is growing its sales faster?
Novartis is growing its sales faster: +4.70% over the past year, against −13.30%.
- YPSN.SW
Which has borrowed less?
Ypsomed Holding has borrowed less: its debt is 34.9% of what its shareholders own, against 128.6% for Novartis.
- NOVN.SW
Which costs less for the profit it is expected to make?
Novartis costs less for the profit it is expected to make: 15.9× its forward earnings, against 28.8×.
- NOVN.SW
Which pays more in dividends?
Novartis pays more back in dividends for what a share costs: 2.78% a year, against 1.04%.
- YPSN.SW
Which do analysts rate higher?
Analysts are warmer on Ypsomed Holding: Buy, against Hold for Novartis.
- YPSN.SW
Which is in the stronger price trend?
Ypsomed Holding's price is in the stronger trend: 21.2% above its 200-day average, against 9.2% above.
What each company does
NOVN.SWNovartis
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Reports results on 3 February 2027
YPSN.SWYpsomed Holding
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Reports results on 19 May 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.